D-0175-2021 Class III Terminated

Recalled by US Compounding Inc — Conway, AR

FDA drug recall D-0175-2021 was initiated by US Compounding Inc on Nov 25, 2020 and is designated Class III. Reason for recall: Labelling: Missing label. The recall status is terminated (terminated Nov 5, 2021). Affected quantity: 1640 syringes.

Recall Details

Product Type
Drugs
Report Date
Jan 6, 2021
Initiation Date
Nov 25, 2020
Termination Date
Nov 5, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1640 syringes

Product Description

Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05

Reason for Recall

Labelling: Missing label.

Distribution Pattern

Nationwide

Code Information

Lot: 20202109@3 BUD: 3/20/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0175-2021
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0175-2021. Report a data issue: hello@regdatalab.com.